In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers.
The COVID-19 pandemic has put the inequality in health outcomes in the United States center stage. What can the healthcare industry do to begin to address disparities in health outcomes?
Expanding traditional value frameworks to include inequality and factors that contribute to this is the first step to addressing disparities in health outcomes.
Watch PRECISIONheor’s Jeroen Jansen, and partner David Phillippo, as they provide an introduction to a novel method, called multilevel network meta-regression (ML-NMR). The method addresses several limitations with current methods, including synthesizing networks of any size and availability of IPD or aggregate studies, and – crucially for decision-making – producing estimates in any target population of interest.
Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
